- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.80 Å
- Oligo State
- homo-18-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.2: 5 residues within 4Å:- Chain A: N.396, E.397, H.399, S.426
- Chain E: T.453
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:T.453, A:S.426
NAG-NAG-BMA-MAN.5: 5 residues within 4Å:- Chain B: N.396, E.397, H.399, S.426
- Chain F: T.453
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.426
NAG-NAG-BMA-MAN.7: 5 residues within 4Å:- Chain C: N.396, T.398, H.399, S.426
- Chain D: T.453
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.426
NAG-NAG-BMA-MAN.9: 5 residues within 4Å:- Chain A: T.453
- Chain D: N.396, E.397, H.399, S.426
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain A- Hydrogen bonds: D:S.426, A:T.453
NAG-NAG-BMA-MAN.12: 4 residues within 4Å:- Chain B: T.453
- Chain E: N.396, H.399, S.426
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain B- Hydrogen bonds: E:S.426, B:T.453
NAG-NAG-BMA-MAN.16: 6 residues within 4Å:- Chain G: N.396, T.398, H.399, S.426
- Chain K: G.452, T.453
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.19: 6 residues within 4Å:- Chain H: N.396, T.398, H.399, S.426
- Chain L: G.452, T.453
2 PLIP interactions:2 interactions with chain H- Hydrogen bonds: H:S.426, H:S.426
NAG-NAG-BMA-MAN.21: 5 residues within 4Å:- Chain I: N.396, E.397, H.399, S.426
- Chain J: T.453
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.23: 5 residues within 4Å:- Chain G: T.453
- Chain J: N.396, E.397, H.399, S.426
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.26: 5 residues within 4Å:- Chain H: T.453
- Chain K: N.396, T.398, H.399, S.426
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.30: 5 residues within 4Å:- Chain M: N.396, E.397, T.398, H.399, S.426
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:S.426
NAG-NAG-BMA-MAN.33: 7 residues within 4Å:- Chain N: N.396, E.397, T.398, H.399, S.426
- Chain R: G.452, T.453
2 PLIP interactions:2 interactions with chain N- Hydrogen bonds: N:S.426, N:S.426
NAG-NAG-BMA-MAN.35: 5 residues within 4Å:- Chain O: N.396, T.398, H.399, S.426
- Chain P: T.453
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.37: 6 residues within 4Å:- Chain M: G.452, T.453
- Chain P: N.396, E.397, H.399, S.426
2 PLIP interactions:2 interactions with chain P- Hydrogen bonds: P:S.426, P:S.426
NAG-NAG-BMA-MAN.40: 6 residues within 4Å:- Chain N: G.452, T.453
- Chain Q: N.396, T.398, H.399, S.426
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 4 residues within 4Å:- Chain A: N.232, K.246, C.248, D.259
Ligand excluded by PLIPNAG.44: 5 residues within 4Å:- Chain B: N.232, G.233, K.246, C.248, D.259
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain C: N.232, K.246, C.248, D.259
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain D: N.232, D.259
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain E: N.232, G.233, K.246, D.259
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain G: N.232, G.233, K.246, D.259
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain H: N.232, K.246, D.259
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain I: N.232, K.246, C.248, D.259
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain J: N.232, K.246, C.248, D.259
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain K: N.232, K.246, D.259
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain M: N.232, G.233, K.246, C.248, C.256, D.259
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain N: N.232, K.246, D.259
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain O: N.232, K.246, D.259
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain P: N.232, G.233, K.246, C.248, D.259
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain Q: N.232, K.246, C.248, C.256, D.259
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A.N. et al., Structural basis of human uromodulin filament networks in uropathogen capture. Structure (2025)
- Release Date
- 2025-05-21
- Peptides
- Uromodulin: ABCDEFGHIJKLMNOPQR
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
DE
EF
FG
KH
GI
IJ
MK
OL
QM
LN
HO
JP
NQ
PR
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 4.80 Å
- Oligo State
- homo-18-mer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A.N. et al., Structural basis of human uromodulin filament networks in uropathogen capture. Structure (2025)
- Release Date
- 2025-05-21
- Peptides
- Uromodulin: ABCDEFGHIJKLMNOPQR
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
AC
BD
DE
EF
FG
KH
GI
IJ
MK
OL
QM
LN
HO
JP
NQ
PR
R